Innovations in advanced wound care dressings have changed the paradigm of health care standards since the last decade. Moist wound dressings are the most widely used dressings in treatment of wounds. Increasing preference for moist wound dressings is attributed to factors like maintenance of optimum moisture levels for cell growth and proliferation, and expedition in the phases of wound healing. Moist wound dressings offer advantages such as proper exudate management, and less pain and scarring as compared to conventional dressings which results in quicker wound closure. The design of moist wound dressings includes layers such as a protective outer layer, absorbent polymer fibers, absorbent layer, non-adherent contact layer, and flat adhesive layer. The several advantages associated with use of moist wound dressings include autolytic debridement, effective functioning of keratinocytes, collagen and growth factors, reduced scarring and pain, as well as faster wound healing.
Technological advancements related to matrix polymer design having superior absorption of exudate in moist wound dressings have led to significant reduction in opportunistic infections, along with reduced cost and minimum disruption of wound bed by reducing maceration. The market is witnessing growing trend of collaborations and licensing agreements between major and emerging market players. Increasing prevalence of diabetes, rising awareness regarding treatment compliance in wound management, growing investments in long term care centers, and skilled nursing facilities are anticipated to contribute to the growth of the market. However, resistance of medical professionals to change treatment regimens with advanced products, and lack of system that alarms the possibility of ulcer are projected to restrain the growth of the market.
The global moist wound dressings market has been segmented on the basis of product type, disease indications, end-user, and region. In terms of product type, the market has been segmented into thin film dressings, hydrofiber dressings, hydrogel dressings, hydrocolloid dressings, alginate dressings, foam dressings, and collagen dressings. In terms of disease indications, the market has been categorized into diabetic foot ulcers, lower limb ulcers, pressure ulcers, surgical and traumatic wounds, and burns. Diabetic foot ulcers is projected to dominate the market owing to factors like exponentially rising diabetic population, rising awareness about treatment of diabetic foot ulcers, etc. Based on end-user, the market has been divided into hospitals, clinics, long term care centers, skilled nursing facilities, and ambulatory care centers.
In terms of regions, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to witness continual growth owing to increasing market penetration of local manufacturers, continuous advancements in healthcare infrastructure, and highest share in the global diabetic population which is prone to develop diabetic foot ulcers. North America, followed by Europe, is expected to dominate the global moist wound dressings market during the forecast period due to rising awareness regarding treatment compliance, and availability of a wide range of products. Superior technological innovations in the design of absorbent polymer matrix of moist wound dressings is projected to fuel the growth of the market in the near future.
Development of proper reimbursement policies is an increasing trend seen among developed countries, which has resulted in rising number of local market players. Increasing initiatives by governments in developed as well as developing countries for treatment awareness serves as a major opportunity for players operating in the global market. Collaborations between universities and major market players to develop innovative moist wound dressings is anticipated to steer the growth of the market. Major market players operating in the global moist wound dressings market are 3M Company, Coloplast A/S, Acelity L.P., Inc., BSN Medical GmbH, ConvaTec, Inc., Medline Industries, Inc., B. Braun Melsungen AG, Molnlycke Health Care AB, Medtronic, Smith & Nephew plc., Hollister Incorporated, Laboratoires URGO, Integra LifeSciences Holdings Corporation, and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.